The Network aims to promote multi-disciplinary approaches to address challenging vaccine-related questions. This page contains a curated list of publications that highlight high-impact and collaborative approaches.


BibTex format

author = {Crepin, VF and Collins, JW and Habibzay, M and Frankel, G},
doi = {10.1038/nprot.2016.100},
journal = {Nature Protocols},
pages = {1851--1876},
title = {Citrobacter rodentium mouse model of bacterial infection.},
url = {},
volume = {11},
year = {2016}

RIS format (EndNote, RefMan)

AB - Infection of mice with Citrobacter rodentium is a robust model to study bacterial pathogenesis, mucosal immunology, the health benefits of probiotics and the role of the microbiota during infection. C. rodentium was first isolated by Barthold from an outbreak of mouse diarrhea in Yale University in 1972 and was 'rediscovered' by Falkow and Schauer in 1993. Since then the use of the model has proliferated, and it is now the gold standard for studying virulence of the closely related human pathogens enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC, respectively). Here we provide a detailed protocol for various applications of the model, including bacterial growth, site-directed mutagenesis, mouse inoculation (from cultured cells and after cohabitation), monitoring of bacterial colonization, tissue extraction and analysis, immune responses, probiotic treatment and microbiota analysis. The main protocol, from mouse infection to clearance and analysis of tissues and host responses, takes ∼5 weeks to complete.
AU - Crepin,VF
AU - Collins,JW
AU - Habibzay,M
AU - Frankel,G
DO - 10.1038/nprot.2016.100
EP - 1876
PY - 2016///
SN - 1754-2189
SP - 1851
TI - Citrobacter rodentium mouse model of bacterial infection.
T2 - Nature Protocols
UR -
VL - 11
ER -